Cargando…
Effects of sleeve gastrectomy on insulin resistance
BACKGROUND AND AIM: Obesity is a major risk factor for the onset of insulin resistance (IR), hyperinsulinemia and type 2 diabetes mellitus (T2DM) Evidence data has proven that beyond important weight loss bariatric surgery especially Roux-en-Y gastric bypass (RYGB) and bilio-pancreatic diversion (BP...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iuliu Hatieganu University of Medicine and Pharmacy
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849386/ https://www.ncbi.nlm.nih.gov/pubmed/27152079 http://dx.doi.org/10.15386/cjmed-576 |
_version_ | 1782429532624519168 |
---|---|
author | CĂTOI, ADRIANA FLORINELA PÂRVU, ALINA MIRONIUC, AUREL GALEA, ROMEO FLORIN MUREŞAN, ADRIANA BIDIAN, CRISTINA POP, IOANA |
author_facet | CĂTOI, ADRIANA FLORINELA PÂRVU, ALINA MIRONIUC, AUREL GALEA, ROMEO FLORIN MUREŞAN, ADRIANA BIDIAN, CRISTINA POP, IOANA |
author_sort | CĂTOI, ADRIANA FLORINELA |
collection | PubMed |
description | BACKGROUND AND AIM: Obesity is a major risk factor for the onset of insulin resistance (IR), hyperinsulinemia and type 2 diabetes mellitus (T2DM) Evidence data has proven that beyond important weight loss bariatric surgery especially Roux-en-Y gastric bypass (RYGB) and bilio-pancreatic diversion (BPD) leads to significant early reduction of insulinemia and of IR calculated through the homeostatic model assessment (HOMA-IR), independently of fat mass decrease. Sleeve gastrectomy (SG) is now used as a sole weight loss operation with good results. Therefore, the aim of the present study was to investigate the early changes of fasting blood glucose, insulin and HOMA-IR in a group of morbidly obese (MO) patients i.e. at 7, 30 and 90 days after SG. METHODS: The study included 20 MO patients (7 male and 13 female) submitted to SG. Anthropometrical (weight, body mass index –BMI, percent excess BMI loss -%EBMIL) and biochemical (plasma glucose, insulin and calculated HOMA-IR ) evaluation were performed before and at 7, 30 and 90 days after SG. In addition, a second group of 10 normal weight healthy subjects with a BMI ranging form 19 kg/m(2) to 23.14 kg/m(2), matched for age and gender was investigated. RESULTS: Plasma glucose (p=0.018), insulin (p=0.004) and HOMA-IR (p=0.006) values were statistically different between the studied groups. After surgery, at every follow-up point, there were statistically different weight and BMI mean values relative to the operation day (p<0.003). BMI, decreased at 7 days (estimated reduction=2.79; 95% CI:[2.12;3.45]), at 30 days (estimated reduction=5.65; 95% CI:[3.57;7.73]) and at 90 days (estimated reduction=10.88; 95% CI:[7.35;14.41]) respectively after SG. We noted a tendency toward statistical significant change of mean insulin values at 7 days after surgery (corrected p=0.075), no statistical change at 30 days (corrected p=0.327) and a significant change at 90 days (corrected p=0.027) after SG as compared to baseline. There was a significant change in mean values of HOMA-IR at 30 days (corrected p=0.009) and at 90 days (corrected p=0.021) after the operation day. CONCLUSIONS: The present study showed important early changes consisting in reductions of mean values of plasma insulin and HOMA-IR after SG. |
format | Online Article Text |
id | pubmed-4849386 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Iuliu Hatieganu University of Medicine and Pharmacy |
record_format | MEDLINE/PubMed |
spelling | pubmed-48493862016-05-05 Effects of sleeve gastrectomy on insulin resistance CĂTOI, ADRIANA FLORINELA PÂRVU, ALINA MIRONIUC, AUREL GALEA, ROMEO FLORIN MUREŞAN, ADRIANA BIDIAN, CRISTINA POP, IOANA Clujul Med Original Research BACKGROUND AND AIM: Obesity is a major risk factor for the onset of insulin resistance (IR), hyperinsulinemia and type 2 diabetes mellitus (T2DM) Evidence data has proven that beyond important weight loss bariatric surgery especially Roux-en-Y gastric bypass (RYGB) and bilio-pancreatic diversion (BPD) leads to significant early reduction of insulinemia and of IR calculated through the homeostatic model assessment (HOMA-IR), independently of fat mass decrease. Sleeve gastrectomy (SG) is now used as a sole weight loss operation with good results. Therefore, the aim of the present study was to investigate the early changes of fasting blood glucose, insulin and HOMA-IR in a group of morbidly obese (MO) patients i.e. at 7, 30 and 90 days after SG. METHODS: The study included 20 MO patients (7 male and 13 female) submitted to SG. Anthropometrical (weight, body mass index –BMI, percent excess BMI loss -%EBMIL) and biochemical (plasma glucose, insulin and calculated HOMA-IR ) evaluation were performed before and at 7, 30 and 90 days after SG. In addition, a second group of 10 normal weight healthy subjects with a BMI ranging form 19 kg/m(2) to 23.14 kg/m(2), matched for age and gender was investigated. RESULTS: Plasma glucose (p=0.018), insulin (p=0.004) and HOMA-IR (p=0.006) values were statistically different between the studied groups. After surgery, at every follow-up point, there were statistically different weight and BMI mean values relative to the operation day (p<0.003). BMI, decreased at 7 days (estimated reduction=2.79; 95% CI:[2.12;3.45]), at 30 days (estimated reduction=5.65; 95% CI:[3.57;7.73]) and at 90 days (estimated reduction=10.88; 95% CI:[7.35;14.41]) respectively after SG. We noted a tendency toward statistical significant change of mean insulin values at 7 days after surgery (corrected p=0.075), no statistical change at 30 days (corrected p=0.327) and a significant change at 90 days (corrected p=0.027) after SG as compared to baseline. There was a significant change in mean values of HOMA-IR at 30 days (corrected p=0.009) and at 90 days (corrected p=0.021) after the operation day. CONCLUSIONS: The present study showed important early changes consisting in reductions of mean values of plasma insulin and HOMA-IR after SG. Iuliu Hatieganu University of Medicine and Pharmacy 2016 2016-04-15 /pmc/articles/PMC4849386/ /pubmed/27152079 http://dx.doi.org/10.15386/cjmed-576 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License |
spellingShingle | Original Research CĂTOI, ADRIANA FLORINELA PÂRVU, ALINA MIRONIUC, AUREL GALEA, ROMEO FLORIN MUREŞAN, ADRIANA BIDIAN, CRISTINA POP, IOANA Effects of sleeve gastrectomy on insulin resistance |
title | Effects of sleeve gastrectomy on insulin resistance |
title_full | Effects of sleeve gastrectomy on insulin resistance |
title_fullStr | Effects of sleeve gastrectomy on insulin resistance |
title_full_unstemmed | Effects of sleeve gastrectomy on insulin resistance |
title_short | Effects of sleeve gastrectomy on insulin resistance |
title_sort | effects of sleeve gastrectomy on insulin resistance |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849386/ https://www.ncbi.nlm.nih.gov/pubmed/27152079 http://dx.doi.org/10.15386/cjmed-576 |
work_keys_str_mv | AT catoiadrianaflorinela effectsofsleevegastrectomyoninsulinresistance AT parvualina effectsofsleevegastrectomyoninsulinresistance AT mironiucaurel effectsofsleevegastrectomyoninsulinresistance AT galearomeoflorin effectsofsleevegastrectomyoninsulinresistance AT muresanadriana effectsofsleevegastrectomyoninsulinresistance AT bidiancristina effectsofsleevegastrectomyoninsulinresistance AT popioana effectsofsleevegastrectomyoninsulinresistance |